Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

GSK plc has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted the company's regulatory ...

Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted UK pharma major GSK’s regulatory application to expand the ...

The Global Albumin Market is expected to grow at a rate of 6% by 2026. The development of albumin-based nanoparticles for drug delivery, high demand for albumin in R&D activities & clinical trials, ...

Martin Vollmer, biopharma program manager at Agilent Technologies, spoke to LCGC International about the evolving importance of glucagon-like peptide-1 (GLP-1) therapeutics and the challenges they ...

Non-Oncology Biopharmaceuticals Market to hit US$ 313.70B by 2033, driven by rising demand for biologics, biosimilars & gene therapies for rare diseases.

The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI ...

Shilpa Medicare inks commercial supply deal with Orion for innovative recombinant human albumin: Our Bureau, Bengaluru Friday, June 13, 2025, 14:40 Hrs [IST] Shilpa Biocare, a ful ...

Diseases caused by human papillomavirus (HPV), such as cervical cancer, may have a new treatment option thanks to a technology developed by researchers at Imunotera Soluções Terapêuticas, a São Paulo ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...